Back
Enovis Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
43
ENOV
Enovis
Last Price:
44.92
Seasonality Move:
3.11%
Sell
44
RARE
Ultragenyx Pharmaceutical
Last Price:
41.54
Seasonality Move:
-0.9%
Sell
43
Enovis (ENOV)
is a Sell
Is Enovis a Buy, Sell or Hold?
- The current Enovis [ENOV] share price is $45.08. The Score for ENOV is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- ENOV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENOV Stock Price Chart
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $40.50
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.
ENOV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.74 | Sell |
| Relative Strength Index (14 RSI): | 30.94 | Sell |
| Chaikin Money Flow: | 299467 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.81 - 49.51) | Sell |
| Bollinger Bands (100): | (49.6 - 61.32) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 49.22 | Sell |
| Chaikin Money Flow: | 494801 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.79 - 41.97) | Buy |
| Bollinger Bands (100): | (40.81 - 48.79) | Sell |
ENOV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.9 | Buy |
| 20-day SMA: | 46.38 | Sell |
| 50-day SMA: | 50.38 | Sell |
| 200-day SMA: | 53.84 | Sell |
| 8-day EMA: | 45.12 | Sell |
| 20-day EMA: | 46.45 | Sell |
| 50-day EMA: | 49.88 | Sell |
| 200-day EMA: | 54.27 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.2 | Buy |
| 20-day SMA: | 40.42 | Buy |
| 50-day SMA: | 41.53 | Sell |
| 200-day SMA: | 42.45 | Sell |
| 8-day EMA: | 39.89 | Buy |
| 20-day EMA: | 40.39 | Buy |
| 50-day EMA: | 41.79 | Sell |
| 200-day EMA: | 43.35 | Sell |
Enovis Earnings Growth & ENOV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.13 per share, an increase this year of $0.27 per share, and an increase next year of $0.45 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Enovis Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||